{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:47:11Z","timestamp":1793148431729,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002537"],"award-info":[{"award-number":["UL1TR002537"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jid.2023.02.012","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T21:17:53Z","timestamp":1677791873000},"page":"1479-1486.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Disease Endotypes Predict the Severity of Mucous Membrane Pemphigoid"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8203-0486","authenticated-orcid":false,"given":"Janet A.","family":"Fairley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7732-3778","authenticated-orcid":false,"given":"Tyler P.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7475-3011","authenticated-orcid":false,"given":"Maryam","family":"Fakhimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0292-7224","authenticated-orcid":false,"given":"Samuel J.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7170-6655","authenticated-orcid":false,"given":"Mark A.","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9989-9671","authenticated-orcid":false,"given":"John W.","family":"Hellstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1861-5770","authenticated-orcid":false,"given":"Douglas J.","family":"Van Daele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4630-0722","authenticated-orcid":false,"given":"Kelly N.","family":"Messingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2023.02.012_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/1523-1747.ep12329728","article-title":"Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain","volume":"106","author":"Balding","year":"1996","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.02.012_bib2","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.4049\/jimmunol.165.5.2824","article-title":"The autoantibodies to alpha 6 beta 4 integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human beta 4","volume":"165","author":"Bhol","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2023.02.012_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.clim.2006.10.007","article-title":"Oral pemphigoid autoantibodies preferentially target BP180 ectodomain","volume":"122","author":"Calabresi","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jid.2023.02.012_bib4","first-page":"768","volume":"96","author":"Cozzani","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2023.02.012_bib32","doi-asserted-by":"crossref","first-page":"104384","DOI":"10.1016\/j.ebiom.2022.104348","article-title":"Equitable endotyping is essential to achieve a global standard of precise, effective, and locally-relevant sepsis care","volume":"86","author":"Cummings","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jid.2023.02.012_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277357","article-title":"Proteomic profiling of serum identifies a molecular signature that correlates with clinical outcomes in COPD","volume":"17","author":"Dagher","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2023.02.012_bib5","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/S0140-6736(00)04971-0","article-title":"Anti-epiligrin cicatricial pemphigoid and relative risk for cancer","volume":"357","author":"Egan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2023.02.012_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2012.09.012","article-title":"Missing the target: characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay","volume":"68","author":"Fairley","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.02.012_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.0022-202X.2005.23853.x","article-title":"Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid","volume":"125","author":"Fairley","year":"2005","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.02.012_bib8","doi-asserted-by":"crossref","first-page":"103119","DOI":"10.1016\/j.autrev.2022.103119","article-title":"Use of rituximab in the treatment of mucous membrane pemphigoid: an analytic review","volume":"21","author":"Farooq","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jid.2023.02.012_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0190-9622(92)70161-8","article-title":"Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies","volume":"27","author":"Gammon","year":"1992","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.02.012_bib10","article-title":"Anti-laminin 332 antibody detection using biochip immunofluorescence microscopy in a real-life cohort of Italian patients with mucous membrane pemphigoid","author":"Gasparini","year":"2021","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jid.2023.02.012_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1684\/ejd.2009.0740","article-title":"Immune diagnosis of pure ocular mucous membrane pemphigoid: indirect immunofluorescence versus immunoblot","volume":"19","author":"Jonkman","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jid.2023.02.012_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fimmu.2019.00034","article-title":"The diagnosis and blistering mechanisms of mucous membrane pemphigoid","volume":"10","author":"Kamaguchi","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2023.02.012_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","article-title":"Understanding asthma phenotypes, endotypes, and mechanisms of disease","volume":"56","author":"Kuruvilla","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jid.2023.02.012_bib14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0190-9622(96)90604-0","article-title":"Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol\/L salt-split skin. Specificity, sensitivity, and practical considerations","volume":"35","author":"Lazarova","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.02.012_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1684\/ejd.2016.2772","article-title":"Integrin \u03b24 is a major target antigen in pure ocular mucous membrane pemphigoid","volume":"26","author":"Li","year":"2016","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jid.2023.02.012_bib16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaad.2014.08.024","article-title":"Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts","volume":"72","author":"Murrell","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.02.012_bib17","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/jdv.17397","article-title":"European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I","volume":"35","author":"Rashid","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2023.02.012_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaad.2021.11.061","volume":"87","author":"Rashid","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.02.012_bib19","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamadermatol.2021.1036","article-title":"Assessment of diagnostic strategy for mucous membrane pemphigoid","volume":"157","author":"Rashid","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2023.02.012_bib20","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.1167\/iovs.12-11404","article-title":"Identification of epitopes within integrin \u03b24 for binding of auto-antibodies in ocular cicatricial and mucous membrane pemphigoid: preliminary report","volume":"54","author":"Rashid","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jid.2023.02.012_bib21","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1038\/sj.jid.5700465","article-title":"Antigen specificity in subsets of mucous membrane pemphigoid","volume":"126","author":"Rashid","year":"2006","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.02.012_bib22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2230.2006.02151.x","article-title":"Rituximab in refractory autoimmune bullous diseases","volume":"31","author":"Schmidt","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2023.02.012_bib23","first-page":"1926","volume":"35","author":"Schmidt","year":"2021","journal-title":"European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II. J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2023.02.012_bib24","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1046\/j.1365-2133.2001.04471.x","article-title":"Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180","volume":"145","author":"Schmidt","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2023.02.012_bib25","doi-asserted-by":"crossref","first-page":"14714","DOI":"10.1073\/pnas.93.25.14714","article-title":"Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization","volume":"93","author":"Tyagi","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2023.02.012_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jamadermatol.2021.4773","article-title":"Evaluation of site- and autoantigen-specific characteristics of mucous membrane pemphigoid","volume":"158","author":"van Beek","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2023.02.012_bib27","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.bbrc.2006.09.147","article-title":"The NC16A domain of collagen XVII plays a role in triple helix assembly and stability","volume":"350","author":"Van den Bergh","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jid.2023.02.012_bib28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2012.09.012","article-title":"Missing the target: characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay","volume":"68","author":"Fairley","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2023.02.012_bib29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.0022-202X.2005.23853.x","article-title":"Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid","volume":"125","author":"Fairley","year":"2005","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2023.02.012_bib30","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.bbrc.2006.09.147","article-title":"The NC16A domain of collagen XVII plays a role in triple helix assembly and stability","volume":"350","author":"Van den Bergh","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jid.2023.02.012_bib31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/1523-1747.ep12337492","article-title":"Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies","volume":"109","author":"Zillikens","year":"1997","journal-title":"J\u00a0Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23001082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X23001082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:52:40Z","timestamp":1762206760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X23001082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0022202X23001082"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2023.02.012","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease Endotypes Predict the Severity of Mucous Membrane Pemphigoid","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2023.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}